Home › Lupus › Colorado › Aurora
Lupus clinical trials in Aurora, CO
6 studies for Lupus are looking for participants at sites in and around Aurora (within about 30 miles). Open a study to see who can join and how to contact the study team.
Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →
A Study to Evaluate the Efficacy and Safety of Dapirolizumab Pegol in Study Participants With Moderately to Severely Active Systemic Lupus Erythematosus
RecruitingPhase 3
- Sl0044 50719, Aurora
Study of Efficacy and Safety of LNP023 in Participants With Active Lupus Nephritis Class III-IV, +/- V
RecruitingPhase 2
- University of Colorado Denver, Aurora
Phase 3 Extension Study to Evaluate Long-term Safety of Ianalumab in Participants With Systemic Lupus Erythematosus (SIRIUS-SLE Extension).
RecruitingPhase 3
- University of Colorado Denver, Aurora
A Study to Investigate the Safety and Preliminary Efficacy of ALLO-329, an Allogeneic CAR T-cell Therapy, in Adults With Autoimmune Disease
RecruitingPhase 1
- University of Colorado Denver, Aurora
A Phase 2 Master Protocol Assessing Inebilizumab and Blinatumomab in Autoimmune Diseases
RecruitingPhase 2
- University of Colorado, Aurora
A Study of GSK4527363 in Healthy Participants, Systemic Lupus Erythematosus (SLE) Participants, Healthy Chinese, and Japanese Participants and CTD-ILD Participants
RecruitingPhase 1Healthy volunteers welcome
- GSK Investigational Site, Aurora
About Lupus
Lupus is an autoimmune disease that causes your immune system to attack your healthy tissues and cells. This can cause damage to many parts of your body.
More about Lupus on MedlinePlus
Lupus trials in other cities
- New York City, NY18 studies
- Houston, TX13 studies
- Durham, NC12 studies
- Washington, DC10 studies
- Miami, FL10 studies
- Tampa, FL9 studies
- Philadelphia, PA9 studies
- Clearwater, FL8 studies
- Santa Monica, CA8 studies
- Oklahoma City, OK8 studies
- Boston, MA8 studies
- Los Angeles, CA8 studies
Other studies in Aurora
- Cancer (all types)35 studies
- Colorectal Cancer32 studies
- Non-Small Cell Lung Cancer30 studies
- Breast Cancer27 studies
- Metastatic Cancer25 studies
- Ovarian Cancer25 studies
- Type 1 Diabetes23 studies
- Obesity21 studies
- Lung Cancer19 studies
- Prostate Cancer19 studies
- Heart Failure18 studies
- Melanoma18 studies
From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.